nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—CYP3A4—bone cancer	0.497	1	CbGaD
Perphenazine—AOX1—Methotrexate—bone cancer	0.147	0.553	CbGbCtD
Perphenazine—CYP2B6—Cisplatin—bone cancer	0.0435	0.164	CbGbCtD
Perphenazine—CYP2B6—Doxorubicin—bone cancer	0.0292	0.11	CbGbCtD
Perphenazine—CYP2C9—Cisplatin—bone cancer	0.023	0.0865	CbGbCtD
Perphenazine—CYP2D6—Doxorubicin—bone cancer	0.0141	0.053	CbGbCtD
Perphenazine—CYP3A4—Doxorubicin—bone cancer	0.00896	0.0337	CbGbCtD
Perphenazine—Slurred speech—Cisplatin—bone cancer	0.00234	0.0293	CcSEcCtD
Perphenazine—CALM1—trigeminal nerve—bone cancer	0.00201	0.124	CbGeAlD
Perphenazine—Faecaloma—Epirubicin—bone cancer	0.00188	0.0235	CcSEcCtD
Perphenazine—Faecalith—Epirubicin—bone cancer	0.00188	0.0235	CcSEcCtD
Perphenazine—HRH1—nose—bone cancer	0.00187	0.115	CbGeAlD
Perphenazine—Inappropriate antidiuretic hormone secretion—Cisplatin—bone cancer	0.0018	0.0225	CcSEcCtD
Perphenazine—Faecalith—Doxorubicin—bone cancer	0.00174	0.0218	CcSEcCtD
Perphenazine—Faecaloma—Doxorubicin—bone cancer	0.00174	0.0218	CcSEcCtD
Perphenazine—Retinal disorder—Methotrexate—bone cancer	0.00161	0.0201	CcSEcCtD
Perphenazine—CALM1—cranial nerve—bone cancer	0.00143	0.088	CbGeAlD
Perphenazine—HTR7—cranial nerve—bone cancer	0.0014	0.086	CbGeAlD
Perphenazine—Infection—Carboplatin—bone cancer	0.00126	0.0158	CcSEcCtD
Perphenazine—Liver injury—Cisplatin—bone cancer	0.00124	0.0156	CcSEcCtD
Perphenazine—HTR2A—trigeminal nerve—bone cancer	0.00122	0.0753	CbGeAlD
Perphenazine—Sudden death—Methotrexate—bone cancer	0.00112	0.014	CcSEcCtD
Perphenazine—Dysarthria—Cisplatin—bone cancer	0.00111	0.0138	CcSEcCtD
Perphenazine—Pain—Carboplatin—bone cancer	0.00109	0.0136	CcSEcCtD
Perphenazine—Hepatocellular injury—Cisplatin—bone cancer	0.00105	0.0131	CcSEcCtD
Perphenazine—Body temperature increased—Carboplatin—bone cancer	0.00101	0.0126	CcSEcCtD
Perphenazine—HTR2A—cranial nerve—bone cancer	0.000872	0.0536	CbGeAlD
Perphenazine—Polyuria—Cisplatin—bone cancer	0.000864	0.0108	CcSEcCtD
Perphenazine—HTR2A—vertebral column—bone cancer	0.000855	0.0526	CbGeAlD
Perphenazine—Haemolytic anaemia—Cisplatin—bone cancer	0.000841	0.0105	CcSEcCtD
Perphenazine—Nasal congestion—Cisplatin—bone cancer	0.000833	0.0104	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Cisplatin—bone cancer	0.000784	0.00982	CcSEcCtD
Perphenazine—Clomipramine—GSTP1—bone cancer	0.000738	0.166	CrCbGaD
Perphenazine—HTR2A—hindlimb—bone cancer	0.000735	0.0452	CbGeAlD
Perphenazine—Orthostatic hypotension—Cisplatin—bone cancer	0.000693	0.00868	CcSEcCtD
Perphenazine—Glycosuria—Epirubicin—bone cancer	0.000663	0.0083	CcSEcCtD
Perphenazine—Blood disorder—Epirubicin—bone cancer	0.000643	0.00805	CcSEcCtD
Perphenazine—Liver injury—Epirubicin—bone cancer	0.000638	0.00799	CcSEcCtD
Perphenazine—HTR2A—appendage—bone cancer	0.00063	0.0388	CbGeAlD
Perphenazine—Pancytopenia—Cisplatin—bone cancer	0.000623	0.0078	CcSEcCtD
Perphenazine—Glycosuria—Doxorubicin—bone cancer	0.000613	0.00768	CcSEcCtD
Perphenazine—Jaundice cholestatic—Epirubicin—bone cancer	0.000611	0.00766	CcSEcCtD
Perphenazine—Amenorrhoea—Epirubicin—bone cancer	0.000611	0.00766	CcSEcCtD
Perphenazine—Dysarthria—Methotrexate—bone cancer	0.000607	0.0076	CcSEcCtD
Perphenazine—Blood disorder—Doxorubicin—bone cancer	0.000595	0.00745	CcSEcCtD
Perphenazine—Liver injury—Doxorubicin—bone cancer	0.00059	0.0074	CcSEcCtD
Perphenazine—Dyskinesia—Epirubicin—bone cancer	0.000571	0.00716	CcSEcCtD
Perphenazine—Dysarthria—Epirubicin—bone cancer	0.000568	0.00711	CcSEcCtD
Perphenazine—Jaundice cholestatic—Doxorubicin—bone cancer	0.000565	0.00708	CcSEcCtD
Perphenazine—Amenorrhoea—Doxorubicin—bone cancer	0.000565	0.00708	CcSEcCtD
Perphenazine—Hepatocellular injury—Epirubicin—bone cancer	0.000537	0.00673	CcSEcCtD
Perphenazine—Bradycardia—Cisplatin—bone cancer	0.000534	0.0067	CcSEcCtD
Perphenazine—Abnormal dreams—Epirubicin—bone cancer	0.000531	0.00665	CcSEcCtD
Perphenazine—Dermatitis contact—Epirubicin—bone cancer	0.000531	0.00665	CcSEcCtD
Perphenazine—Dyskinesia—Doxorubicin—bone cancer	0.000529	0.00662	CcSEcCtD
Perphenazine—Dysarthria—Doxorubicin—bone cancer	0.000525	0.00658	CcSEcCtD
Perphenazine—Salivary hypersecretion—Epirubicin—bone cancer	0.000521	0.00653	CcSEcCtD
Perphenazine—Urine output increased—Methotrexate—bone cancer	0.000519	0.0065	CcSEcCtD
Perphenazine—Gynaecomastia—Methotrexate—bone cancer	0.000513	0.00643	CcSEcCtD
Perphenazine—Hepatocellular injury—Doxorubicin—bone cancer	0.000497	0.00622	CcSEcCtD
Perphenazine—Alimemazine—CYP3A4—bone cancer	0.000492	0.111	CrCbGaD
Perphenazine—Dermatitis contact—Doxorubicin—bone cancer	0.000491	0.00615	CcSEcCtD
Perphenazine—Abnormal dreams—Doxorubicin—bone cancer	0.000491	0.00615	CcSEcCtD
Perphenazine—Salivary hypersecretion—Doxorubicin—bone cancer	0.000482	0.00604	CcSEcCtD
Perphenazine—Photosensitivity—Methotrexate—bone cancer	0.000474	0.00594	CcSEcCtD
Perphenazine—Polyuria—Methotrexate—bone cancer	0.000474	0.00594	CcSEcCtD
Perphenazine—Erythema—Cisplatin—bone cancer	0.000457	0.00573	CcSEcCtD
Perphenazine—Photosensitivity—Epirubicin—bone cancer	0.000444	0.00556	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Methotrexate—bone cancer	0.000441	0.00553	CcSEcCtD
Perphenazine—Muscle spasms—Cisplatin—bone cancer	0.000439	0.00551	CcSEcCtD
Perphenazine—Eczema—Epirubicin—bone cancer	0.000434	0.00543	CcSEcCtD
Perphenazine—Vision blurred—Cisplatin—bone cancer	0.000431	0.0054	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Methotrexate—bone cancer	0.00043	0.00539	CcSEcCtD
Perphenazine—Lethargy—Methotrexate—bone cancer	0.000425	0.00532	CcSEcCtD
Perphenazine—Mequitazine—CYP3A4—bone cancer	0.000424	0.0954	CrCbGaD
Perphenazine—Domperidone—CYP3A4—bone cancer	0.000419	0.0942	CrCbGaD
Perphenazine—Dermatitis exfoliative—Epirubicin—bone cancer	0.000413	0.00517	CcSEcCtD
Perphenazine—Photosensitivity—Doxorubicin—bone cancer	0.000411	0.00515	CcSEcCtD
Perphenazine—Leukopenia—Cisplatin—bone cancer	0.000409	0.00513	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Epirubicin—bone cancer	0.000403	0.00505	CcSEcCtD
Perphenazine—Eczema—Doxorubicin—bone cancer	0.000401	0.00503	CcSEcCtD
Perphenazine—Hypoglycaemia—Epirubicin—bone cancer	0.000399	0.005	CcSEcCtD
Perphenazine—Lethargy—Epirubicin—bone cancer	0.000398	0.00498	CcSEcCtD
Perphenazine—Convulsion—Cisplatin—bone cancer	0.000396	0.00496	CcSEcCtD
Perphenazine—Ataxia—Methotrexate—bone cancer	0.000392	0.00491	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000382	0.00479	CcSEcCtD
Perphenazine—Anaphylactic shock—Cisplatin—bone cancer	0.000373	0.00467	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000373	0.00467	CcSEcCtD
Perphenazine—Cardiac arrest—Epirubicin—bone cancer	0.000371	0.00464	CcSEcCtD
Perphenazine—Infection—Cisplatin—bone cancer	0.000371	0.00464	CcSEcCtD
Perphenazine—Hypoglycaemia—Doxorubicin—bone cancer	0.00037	0.00463	CcSEcCtD
Perphenazine—Lethargy—Doxorubicin—bone cancer	0.000368	0.00461	CcSEcCtD
Perphenazine—Ataxia—Epirubicin—bone cancer	0.000366	0.00459	CcSEcCtD
Perphenazine—Tachycardia—Cisplatin—bone cancer	0.000364	0.00456	CcSEcCtD
Perphenazine—Asthma—Methotrexate—bone cancer	0.00036	0.00451	CcSEcCtD
Perphenazine—Eosinophilia—Methotrexate—bone cancer	0.000356	0.00446	CcSEcCtD
Perphenazine—Orthostatic hypotension—Epirubicin—bone cancer	0.000356	0.00446	CcSEcCtD
Perphenazine—Anorexia—Cisplatin—bone cancer	0.000356	0.00445	CcSEcCtD
Perphenazine—Hypotension—Cisplatin—bone cancer	0.000349	0.00437	CcSEcCtD
Perphenazine—Nefazodone—CYP3A4—bone cancer	0.000348	0.0782	CrCbGaD
Perphenazine—Muscular weakness—Epirubicin—bone cancer	0.000344	0.00431	CcSEcCtD
Perphenazine—Cardiac arrest—Doxorubicin—bone cancer	0.000343	0.0043	CcSEcCtD
Perphenazine—Pancytopenia—Methotrexate—bone cancer	0.000342	0.00428	CcSEcCtD
Perphenazine—Ataxia—Doxorubicin—bone cancer	0.000339	0.00425	CcSEcCtD
Perphenazine—Asthma—Epirubicin—bone cancer	0.000337	0.00422	CcSEcCtD
Perphenazine—Dysphagia—Epirubicin—bone cancer	0.000337	0.00422	CcSEcCtD
Perphenazine—Eosinophilia—Epirubicin—bone cancer	0.000334	0.00418	CcSEcCtD
Perphenazine—Dyspnoea—Cisplatin—bone cancer	0.000333	0.00417	CcSEcCtD
Perphenazine—Orthostatic hypotension—Doxorubicin—bone cancer	0.000329	0.00413	CcSEcCtD
Perphenazine—Photosensitivity reaction—Methotrexate—bone cancer	0.000329	0.00412	CcSEcCtD
Perphenazine—Decreased appetite—Cisplatin—bone cancer	0.000324	0.00406	CcSEcCtD
Perphenazine—Aripiprazole—CYP3A4—bone cancer	0.000323	0.0727	CrCbGaD
Perphenazine—Trazodone—CYP3A4—bone cancer	0.000322	0.0724	CrCbGaD
Perphenazine—Drowsiness—Methotrexate—bone cancer	0.000321	0.00402	CcSEcCtD
Perphenazine—Pancytopenia—Epirubicin—bone cancer	0.00032	0.00401	CcSEcCtD
Perphenazine—Pain—Cisplatin—bone cancer	0.000319	0.004	CcSEcCtD
Perphenazine—Muscular weakness—Doxorubicin—bone cancer	0.000318	0.00398	CcSEcCtD
Perphenazine—Asthma—Doxorubicin—bone cancer	0.000312	0.0039	CcSEcCtD
Perphenazine—Dysphagia—Doxorubicin—bone cancer	0.000312	0.0039	CcSEcCtD
Perphenazine—Eosinophilia—Doxorubicin—bone cancer	0.000309	0.00387	CcSEcCtD
Perphenazine—Photosensitivity reaction—Epirubicin—bone cancer	0.000307	0.00385	CcSEcCtD
Perphenazine—Hyperglycaemia—Epirubicin—bone cancer	0.000304	0.00381	CcSEcCtD
Perphenazine—Pipotiazine—CYP3A4—bone cancer	0.000301	0.0678	CrCbGaD
Perphenazine—Drowsiness—Epirubicin—bone cancer	0.0003	0.00376	CcSEcCtD
Perphenazine—Agranulocytosis—Methotrexate—bone cancer	0.0003	0.00375	CcSEcCtD
Perphenazine—CALM2—connective tissue—bone cancer	0.000297	0.0183	CbGeAlD
Perphenazine—Pancytopenia—Doxorubicin—bone cancer	0.000296	0.00371	CcSEcCtD
Perphenazine—CALM1—connective tissue—bone cancer	0.000295	0.0182	CbGeAlD
Perphenazine—Body temperature increased—Cisplatin—bone cancer	0.000295	0.00369	CcSEcCtD
Perphenazine—Jaundice—Epirubicin—bone cancer	0.000293	0.00367	CcSEcCtD
Perphenazine—HTR7—connective tissue—bone cancer	0.000289	0.0177	CbGeAlD
Perphenazine—AOX1—tendon—bone cancer	0.000288	0.0177	CbGeAlD
Perphenazine—Prochlorperazine—CYP3A4—bone cancer	0.000288	0.0648	CrCbGaD
Perphenazine—Photosensitivity reaction—Doxorubicin—bone cancer	0.000284	0.00356	CcSEcCtD
Perphenazine—Hyperglycaemia—Doxorubicin—bone cancer	0.000281	0.00352	CcSEcCtD
Perphenazine—Agranulocytosis—Epirubicin—bone cancer	0.00028	0.00351	CcSEcCtD
Perphenazine—Drowsiness—Doxorubicin—bone cancer	0.000278	0.00348	CcSEcCtD
Perphenazine—Hypersensitivity—Cisplatin—bone cancer	0.000275	0.00344	CcSEcCtD
Perphenazine—Bradycardia—Epirubicin—bone cancer	0.000274	0.00344	CcSEcCtD
Perphenazine—Jaundice—Doxorubicin—bone cancer	0.000271	0.00339	CcSEcCtD
Perphenazine—Hypoaesthesia—Epirubicin—bone cancer	0.000268	0.00336	CcSEcCtD
Perphenazine—Oedema peripheral—Epirubicin—bone cancer	0.000266	0.00333	CcSEcCtD
Perphenazine—CALM3—tendon—bone cancer	0.00026	0.016	CbGeAlD
Perphenazine—Agranulocytosis—Doxorubicin—bone cancer	0.000259	0.00325	CcSEcCtD
Perphenazine—Diarrhoea—Cisplatin—bone cancer	0.000255	0.0032	CcSEcCtD
Perphenazine—Bradycardia—Doxorubicin—bone cancer	0.000254	0.00318	CcSEcCtD
Perphenazine—CALM3—bone marrow—bone cancer	0.000252	0.0155	CbGeAlD
Perphenazine—Erythema—Methotrexate—bone cancer	0.000251	0.00314	CcSEcCtD
Perphenazine—CALM3—spinal cord—bone cancer	0.000251	0.0154	CbGeAlD
Perphenazine—Hypoaesthesia—Doxorubicin—bone cancer	0.000248	0.00311	CcSEcCtD
Perphenazine—Oedema peripheral—Doxorubicin—bone cancer	0.000246	0.00308	CcSEcCtD
Perphenazine—Clomipramine—CYP3A4—bone cancer	0.000238	0.0536	CrCbGaD
Perphenazine—HTR2C—spinal cord—bone cancer	0.000238	0.0146	CbGeAlD
Perphenazine—Vision blurred—Methotrexate—bone cancer	0.000236	0.00296	CcSEcCtD
Perphenazine—Erythema—Epirubicin—bone cancer	0.000235	0.00294	CcSEcCtD
Perphenazine—Muscle spasms—Epirubicin—bone cancer	0.000226	0.00283	CcSEcCtD
Perphenazine—Leukopenia—Methotrexate—bone cancer	0.000225	0.00281	CcSEcCtD
Perphenazine—Vision blurred—Epirubicin—bone cancer	0.000221	0.00277	CcSEcCtD
Perphenazine—Cough—Methotrexate—bone cancer	0.000219	0.00274	CcSEcCtD
Perphenazine—Convulsion—Methotrexate—bone cancer	0.000217	0.00272	CcSEcCtD
Perphenazine—Erythema—Doxorubicin—bone cancer	0.000217	0.00272	CcSEcCtD
Perphenazine—Agitation—Epirubicin—bone cancer	0.000216	0.0027	CcSEcCtD
Perphenazine—HRH1—connective tissue—bone cancer	0.000215	0.0133	CbGeAlD
Perphenazine—ADRA2A—connective tissue—bone cancer	0.000212	0.013	CbGeAlD
Perphenazine—Syncope—Epirubicin—bone cancer	0.00021	0.00264	CcSEcCtD
Perphenazine—Leukopenia—Epirubicin—bone cancer	0.00021	0.00263	CcSEcCtD
Perphenazine—Muscle spasms—Doxorubicin—bone cancer	0.000209	0.00262	CcSEcCtD
Perphenazine—Confusional state—Methotrexate—bone cancer	0.000206	0.00259	CcSEcCtD
Perphenazine—Loss of consciousness—Epirubicin—bone cancer	0.000206	0.00258	CcSEcCtD
Perphenazine—Cough—Epirubicin—bone cancer	0.000205	0.00257	CcSEcCtD
Perphenazine—Anaphylactic shock—Methotrexate—bone cancer	0.000205	0.00256	CcSEcCtD
Perphenazine—Vision blurred—Doxorubicin—bone cancer	0.000205	0.00256	CcSEcCtD
Perphenazine—CALM2—tendon—bone cancer	0.000204	0.0125	CbGeAlD
Perphenazine—Convulsion—Epirubicin—bone cancer	0.000203	0.00255	CcSEcCtD
Perphenazine—Infection—Methotrexate—bone cancer	0.000203	0.00255	CcSEcCtD
Perphenazine—CALM1—tendon—bone cancer	0.000203	0.0125	CbGeAlD
Perphenazine—Hypertension—Epirubicin—bone cancer	0.000203	0.00254	CcSEcCtD
Perphenazine—Quetiapine—CYP3A4—bone cancer	0.000202	0.0455	CrCbGaD
Perphenazine—HTR1A—spinal cord—bone cancer	0.0002	0.0123	CbGeAlD
Perphenazine—Agitation—Doxorubicin—bone cancer	0.0002	0.0025	CcSEcCtD
Perphenazine—HTR7—tendon—bone cancer	0.000198	0.0122	CbGeAlD
Perphenazine—CALM2—bone marrow—bone cancer	0.000198	0.0122	CbGeAlD
Perphenazine—CALM2—spinal cord—bone cancer	0.000197	0.0121	CbGeAlD
Perphenazine—CALM1—bone marrow—bone cancer	0.000197	0.0121	CbGeAlD
Perphenazine—CALM1—spinal cord—bone cancer	0.000196	0.012	CbGeAlD
Perphenazine—Dry mouth—Epirubicin—bone cancer	0.000195	0.00245	CcSEcCtD
Perphenazine—Anorexia—Methotrexate—bone cancer	0.000195	0.00244	CcSEcCtD
Perphenazine—Syncope—Doxorubicin—bone cancer	0.000195	0.00244	CcSEcCtD
Perphenazine—Leukopenia—Doxorubicin—bone cancer	0.000194	0.00244	CcSEcCtD
Perphenazine—Confusional state—Epirubicin—bone cancer	0.000193	0.00242	CcSEcCtD
Perphenazine—Anaphylactic shock—Epirubicin—bone cancer	0.000192	0.0024	CcSEcCtD
Perphenazine—HTR7—spinal cord—bone cancer	0.000191	0.0118	CbGeAlD
Perphenazine—Hypotension—Methotrexate—bone cancer	0.000191	0.0024	CcSEcCtD
Perphenazine—Loss of consciousness—Doxorubicin—bone cancer	0.000191	0.00239	CcSEcCtD
Perphenazine—Infection—Epirubicin—bone cancer	0.00019	0.00238	CcSEcCtD
Perphenazine—Cough—Doxorubicin—bone cancer	0.00019	0.00237	CcSEcCtD
Perphenazine—Shock—Epirubicin—bone cancer	0.000188	0.00236	CcSEcCtD
Perphenazine—Convulsion—Doxorubicin—bone cancer	0.000188	0.00236	CcSEcCtD
Perphenazine—Hypertension—Doxorubicin—bone cancer	0.000187	0.00235	CcSEcCtD
Perphenazine—Tachycardia—Epirubicin—bone cancer	0.000187	0.00234	CcSEcCtD
Perphenazine—Promazine—CYP3A4—bone cancer	0.000186	0.0418	CrCbGaD
Perphenazine—Insomnia—Methotrexate—bone cancer	0.000185	0.00232	CcSEcCtD
Perphenazine—Anorexia—Epirubicin—bone cancer	0.000183	0.00229	CcSEcCtD
Perphenazine—Dyspnoea—Methotrexate—bone cancer	0.000182	0.00229	CcSEcCtD
Perphenazine—Somnolence—Methotrexate—bone cancer	0.000182	0.00228	CcSEcCtD
Perphenazine—Dry mouth—Doxorubicin—bone cancer	0.000181	0.00227	CcSEcCtD
Perphenazine—HTR2A—connective tissue—bone cancer	0.00018	0.0111	CbGeAlD
Perphenazine—Hypotension—Epirubicin—bone cancer	0.000179	0.00224	CcSEcCtD
Perphenazine—Confusional state—Doxorubicin—bone cancer	0.000179	0.00224	CcSEcCtD
Perphenazine—Decreased appetite—Methotrexate—bone cancer	0.000178	0.00223	CcSEcCtD
Perphenazine—Anaphylactic shock—Doxorubicin—bone cancer	0.000177	0.00222	CcSEcCtD
Perphenazine—Infection—Doxorubicin—bone cancer	0.000176	0.00221	CcSEcCtD
Perphenazine—Pain—Methotrexate—bone cancer	0.000175	0.00219	CcSEcCtD
Perphenazine—Shock—Doxorubicin—bone cancer	0.000174	0.00218	CcSEcCtD
Perphenazine—Insomnia—Epirubicin—bone cancer	0.000173	0.00217	CcSEcCtD
Perphenazine—Tachycardia—Doxorubicin—bone cancer	0.000173	0.00217	CcSEcCtD
Perphenazine—Dyspnoea—Epirubicin—bone cancer	0.000171	0.00214	CcSEcCtD
Perphenazine—Somnolence—Epirubicin—bone cancer	0.00017	0.00213	CcSEcCtD
Perphenazine—Anorexia—Doxorubicin—bone cancer	0.000169	0.00212	CcSEcCtD
Perphenazine—Decreased appetite—Epirubicin—bone cancer	0.000167	0.00209	CcSEcCtD
Perphenazine—Hypotension—Doxorubicin—bone cancer	0.000166	0.00207	CcSEcCtD
Perphenazine—Pain—Epirubicin—bone cancer	0.000164	0.00205	CcSEcCtD
Perphenazine—Constipation—Epirubicin—bone cancer	0.000164	0.00205	CcSEcCtD
Perphenazine—Chlorpromazine—CYP3A4—bone cancer	0.000163	0.0368	CrCbGaD
Perphenazine—Urticaria—Methotrexate—bone cancer	0.000163	0.00204	CcSEcCtD
Perphenazine—Body temperature increased—Methotrexate—bone cancer	0.000162	0.00203	CcSEcCtD
Perphenazine—Insomnia—Doxorubicin—bone cancer	0.00016	0.00201	CcSEcCtD
Perphenazine—Dyspnoea—Doxorubicin—bone cancer	0.000158	0.00198	CcSEcCtD
Perphenazine—Somnolence—Doxorubicin—bone cancer	0.000158	0.00197	CcSEcCtD
Perphenazine—Decreased appetite—Doxorubicin—bone cancer	0.000154	0.00193	CcSEcCtD
Perphenazine—Urticaria—Epirubicin—bone cancer	0.000152	0.00191	CcSEcCtD
Perphenazine—Pain—Doxorubicin—bone cancer	0.000152	0.0019	CcSEcCtD
Perphenazine—Constipation—Doxorubicin—bone cancer	0.000152	0.0019	CcSEcCtD
Perphenazine—Body temperature increased—Epirubicin—bone cancer	0.000151	0.0019	CcSEcCtD
Perphenazine—Hypersensitivity—Methotrexate—bone cancer	0.000151	0.00189	CcSEcCtD
Perphenazine—HRH1—tendon—bone cancer	0.000148	0.00911	CbGeAlD
Perphenazine—ADRA2A—tendon—bone cancer	0.000145	0.00895	CbGeAlD
Perphenazine—Pruritus—Methotrexate—bone cancer	0.000145	0.00181	CcSEcCtD
Perphenazine—Hypersensitivity—Epirubicin—bone cancer	0.000141	0.00177	CcSEcCtD
Perphenazine—Urticaria—Doxorubicin—bone cancer	0.000141	0.00176	CcSEcCtD
Perphenazine—ADRA2A—spinal cord—bone cancer	0.00014	0.00863	CbGeAlD
Perphenazine—Body temperature increased—Doxorubicin—bone cancer	0.00014	0.00176	CcSEcCtD
Perphenazine—Diarrhoea—Methotrexate—bone cancer	0.00014	0.00175	CcSEcCtD
Perphenazine—Pruritus—Epirubicin—bone cancer	0.000136	0.0017	CcSEcCtD
Perphenazine—Dizziness—Methotrexate—bone cancer	0.000135	0.0017	CcSEcCtD
Perphenazine—Diarrhoea—Epirubicin—bone cancer	0.000131	0.00164	CcSEcCtD
Perphenazine—Hypersensitivity—Doxorubicin—bone cancer	0.000131	0.00164	CcSEcCtD
Perphenazine—Headache—Methotrexate—bone cancer	0.000128	0.00161	CcSEcCtD
Perphenazine—Dizziness—Epirubicin—bone cancer	0.000127	0.00159	CcSEcCtD
Perphenazine—Pruritus—Doxorubicin—bone cancer	0.000125	0.00157	CcSEcCtD
Perphenazine—HTR2A—tendon—bone cancer	0.000124	0.00761	CbGeAlD
Perphenazine—Diarrhoea—Doxorubicin—bone cancer	0.000121	0.00152	CcSEcCtD
Perphenazine—Headache—Epirubicin—bone cancer	0.00012	0.0015	CcSEcCtD
Perphenazine—HTR2A—spinal cord—bone cancer	0.000119	0.00734	CbGeAlD
Perphenazine—Dizziness—Doxorubicin—bone cancer	0.000117	0.00147	CcSEcCtD
Perphenazine—Headache—Doxorubicin—bone cancer	0.000111	0.00139	CcSEcCtD
Perphenazine—CALM2—Metabolism—DHFR—bone cancer	2.61e-05	0.000191	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—DHFR—bone cancer	2.61e-05	0.000191	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—GNA11—bone cancer	2.59e-05	0.000189	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—GNA11—bone cancer	2.58e-05	0.000189	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—GNA11—bone cancer	2.54e-05	0.000186	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—GNA11—bone cancer	2.54e-05	0.000185	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—ENO2—bone cancer	2.53e-05	0.000185	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—SMO—bone cancer	2.53e-05	0.000185	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—GNA11—bone cancer	2.52e-05	0.000184	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—CYP3A4—bone cancer	2.51e-05	0.000183	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IGF1R—bone cancer	2.5e-05	0.000182	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—GNA11—bone cancer	2.44e-05	0.000178	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—GNA11—bone cancer	2.44e-05	0.000178	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—ATF1—bone cancer	2.4e-05	0.000175	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—ATF1—bone cancer	2.36e-05	0.000172	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—ATF1—bone cancer	2.36e-05	0.000172	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—CYP3A4—bone cancer	2.35e-05	0.000172	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—DHFR—bone cancer	2.35e-05	0.000171	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL3—bone cancer	2.34e-05	0.000171	CbGpPWpGaD
Perphenazine—CALM3—Disease—TGFBR2—bone cancer	2.34e-05	0.000171	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—MDM2—bone cancer	2.34e-05	0.00017	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—GNA11—bone cancer	2.31e-05	0.000169	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—SMO—bone cancer	2.31e-05	0.000168	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL3—bone cancer	2.31e-05	0.000168	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL3—bone cancer	2.3e-05	0.000168	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—CYP3A4—bone cancer	2.29e-05	0.000167	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TGFBR2—bone cancer	2.28e-05	0.000167	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TGFBR2—bone cancer	2.27e-05	0.000166	CbGpPWpGaD
Perphenazine—CALM2—Disease—TGFBR2—bone cancer	2.26e-05	0.000165	CbGpPWpGaD
Perphenazine—CALM1—Disease—TGFBR2—bone cancer	2.26e-05	0.000165	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—ENO2—bone cancer	2.26e-05	0.000165	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—MDM2—bone cancer	2.26e-05	0.000165	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—MDM2—bone cancer	2.26e-05	0.000165	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—MDM2—bone cancer	2.24e-05	0.000164	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—SMO—bone cancer	2.23e-05	0.000163	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—SMO—bone cancer	2.23e-05	0.000163	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—CYP3A4—bone cancer	2.21e-05	0.000162	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—CYP3A4—bone cancer	2.21e-05	0.000162	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—GNA11—bone cancer	2.2e-05	0.00016	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—MDM2—bone cancer	2.17e-05	0.000158	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—MDM2—bone cancer	2.17e-05	0.000158	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—ATF1—bone cancer	2.15e-05	0.000157	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IGF1R—bone cancer	2.15e-05	0.000157	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—GSTP1—bone cancer	2.15e-05	0.000157	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IGF1R—bone cancer	2.14e-05	0.000156	CbGpPWpGaD
Perphenazine—CYP2C18—Metabolism—PTGS2—bone cancer	2.12e-05	0.000155	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—GNA11—bone cancer	2.11e-05	0.000154	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—KIT—bone cancer	2.1e-05	0.000153	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—KIT—bone cancer	2.1e-05	0.000153	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL3—bone cancer	2.1e-05	0.000153	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—DHFR—bone cancer	2.1e-05	0.000153	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—ENO2—bone cancer	2.08e-05	0.000152	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—ENO2—bone cancer	2.06e-05	0.00015	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—GNA11—bone cancer	2.04e-05	0.000149	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—GNA11—bone cancer	2.04e-05	0.000149	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—JUN—bone cancer	2.03e-05	0.000148	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—GSTP1—bone cancer	2.01e-05	0.000147	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TGFBR2—bone cancer	2e-05	0.000146	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—CYP3A4—bone cancer	1.99e-05	0.000145	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.98e-05	0.000145	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—BRAF—bone cancer	1.98e-05	0.000144	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—BRAF—bone cancer	1.98e-05	0.000144	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TGFBR2—bone cancer	1.97e-05	0.000144	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TGFBR2—bone cancer	1.97e-05	0.000144	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—JUN—bone cancer	1.96e-05	0.000143	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—JUN—bone cancer	1.96e-05	0.000143	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—ATF1—bone cancer	1.96e-05	0.000143	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—GNA11—bone cancer	1.96e-05	0.000143	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—GSTP1—bone cancer	1.96e-05	0.000143	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—DHFR—bone cancer	1.93e-05	0.000141	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—EGFR—bone cancer	1.92e-05	0.00014	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—EGFR—bone cancer	1.91e-05	0.00014	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL3—bone cancer	1.91e-05	0.00014	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—DHFR—bone cancer	1.91e-05	0.00014	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—ATF1—bone cancer	1.9e-05	0.000138	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—ATF1—bone cancer	1.9e-05	0.000138	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—GSTP1—bone cancer	1.89e-05	0.000138	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—GSTP1—bone cancer	1.89e-05	0.000138	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IGF1R—bone cancer	1.89e-05	0.000138	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IGF1R—bone cancer	1.85e-05	0.000135	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL3—bone cancer	1.85e-05	0.000135	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL3—bone cancer	1.85e-05	0.000135	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IGF1R—bone cancer	1.85e-05	0.000135	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—KIT—bone cancer	1.81e-05	0.000132	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—GNA11—bone cancer	1.8e-05	0.000132	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	1.79e-05	0.000131	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—GNA11—bone cancer	1.79e-05	0.00013	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—CYP3A4—bone cancer	1.78e-05	0.00013	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.77e-05	0.000129	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ENO2—bone cancer	1.76e-05	0.000129	CbGpPWpGaD
Perphenazine—CALM3—Immune System—KIT—bone cancer	1.73e-05	0.000126	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—GSTP1—bone cancer	1.7e-05	0.000124	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—BRAF—bone cancer	1.7e-05	0.000124	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IGF1R—bone cancer	1.69e-05	0.000123	CbGpPWpGaD
Perphenazine—CALM2—Immune System—KIT—bone cancer	1.67e-05	0.000122	CbGpPWpGaD
Perphenazine—CALM1—Immune System—KIT—bone cancer	1.67e-05	0.000122	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—MDM2—bone cancer	1.66e-05	0.000121	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—MDM2—bone cancer	1.66e-05	0.000121	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—EGFR—bone cancer	1.65e-05	0.00012	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TGFBR2—bone cancer	1.64e-05	0.000119	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—CYP3A4—bone cancer	1.63e-05	0.000119	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—DHFR—bone cancer	1.63e-05	0.000119	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—TP53—bone cancer	1.63e-05	0.000119	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—CYP3A4—bone cancer	1.62e-05	0.000118	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.61e-05	0.000118	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—EGFR—bone cancer	1.6e-05	0.000116	CbGpPWpGaD
Perphenazine—CALM3—Disease—KIT—bone cancer	1.59e-05	0.000116	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TGFBR2—bone cancer	1.58e-05	0.000116	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TGFBR2—bone cancer	1.58e-05	0.000116	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—KIT—bone cancer	1.56e-05	0.000114	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—KIT—bone cancer	1.55e-05	0.000113	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—EGFR—bone cancer	1.54e-05	0.000113	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—EGFR—bone cancer	1.54e-05	0.000113	CbGpPWpGaD
Perphenazine—CALM2—Disease—KIT—bone cancer	1.54e-05	0.000113	CbGpPWpGaD
Perphenazine—CALM1—Disease—KIT—bone cancer	1.54e-05	0.000113	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IGF1R—bone cancer	1.54e-05	0.000112	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—EGFR—bone cancer	1.53e-05	0.000112	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—GNA11—bone cancer	1.53e-05	0.000111	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—GSTP1—bone cancer	1.52e-05	0.000111	CbGpPWpGaD
Perphenazine—CALM3—Disease—BRAF—bone cancer	1.5e-05	0.000109	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IGF1R—bone cancer	1.49e-05	0.000109	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IGF1R—bone cancer	1.49e-05	0.000109	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—TP53—bone cancer	1.49e-05	0.000109	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—EGFR—bone cancer	1.48e-05	0.000108	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—EGFR—bone cancer	1.48e-05	0.000108	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—BRAF—bone cancer	1.46e-05	0.000107	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—BRAF—bone cancer	1.46e-05	0.000106	CbGpPWpGaD
Perphenazine—CALM2—Disease—BRAF—bone cancer	1.45e-05	0.000106	CbGpPWpGaD
Perphenazine—CALM1—Disease—BRAF—bone cancer	1.45e-05	0.000106	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—JUN—bone cancer	1.44e-05	0.000105	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—TP53—bone cancer	1.44e-05	0.000105	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—TP53—bone cancer	1.44e-05	0.000105	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—JUN—bone cancer	1.44e-05	0.000105	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MDM2—bone cancer	1.43e-05	0.000104	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.42e-05	0.000104	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—EGFR—bone cancer	1.41e-05	0.000103	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—MMP9—bone cancer	1.4e-05	0.000102	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—MMP9—bone cancer	1.4e-05	0.000102	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—GSTP1—bone cancer	1.4e-05	0.000102	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—GSTP1—bone cancer	1.39e-05	0.000101	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CYP3A4—bone cancer	1.38e-05	0.000101	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.38e-05	0.000101	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—KIT—bone cancer	1.37e-05	9.98e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—MDM2—bone cancer	1.36e-05	9.93e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ENO2—bone cancer	1.36e-05	9.92e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—KIT—bone cancer	1.35e-05	9.82e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—KIT—bone cancer	1.34e-05	9.79e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—MDM2—bone cancer	1.32e-05	9.6e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—MDM2—bone cancer	1.32e-05	9.6e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—BRAF—bone cancer	1.29e-05	9.38e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—BRAF—bone cancer	1.26e-05	9.23e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—BRAF—bone cancer	1.26e-05	9.21e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—DHFR—bone cancer	1.26e-05	9.2e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—MDM2—bone cancer	1.26e-05	9.16e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—EGFR—bone cancer	1.25e-05	9.09e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—JUN—bone cancer	1.24e-05	9.04e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MDM2—bone cancer	1.23e-05	8.95e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—EGFR—bone cancer	1.23e-05	8.94e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KIT—bone cancer	1.22e-05	8.93e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—EGFR—bone cancer	1.22e-05	8.92e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MDM2—bone cancer	1.22e-05	8.9e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MDM2—bone cancer	1.21e-05	8.86e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—MDM2—bone cancer	1.21e-05	8.86e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—PTGS2—bone cancer	1.21e-05	8.83e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MMP9—bone cancer	1.21e-05	8.8e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—GSTP1—bone cancer	1.18e-05	8.64e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—JUN—bone cancer	1.18e-05	8.63e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GNA11—bone cancer	1.18e-05	8.6e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—PTGS2—bone cancer	1.17e-05	8.55e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—PTGS2—bone cancer	1.17e-05	8.55e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—BRAF—bone cancer	1.15e-05	8.39e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—JUN—bone cancer	1.14e-05	8.35e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—JUN—bone cancer	1.14e-05	8.35e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—EGFR—bone cancer	1.13e-05	8.26e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—EGFR—bone cancer	1.13e-05	8.25e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KIT—bone cancer	1.12e-05	8.15e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—EGFR—bone cancer	1.12e-05	8.14e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PTGS2—bone cancer	1.11e-05	8.11e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KIT—bone cancer	1.08e-05	7.88e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KIT—bone cancer	1.08e-05	7.88e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MDM2—bone cancer	1.08e-05	7.86e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—JUN—bone cancer	1.07e-05	7.78e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—JUN—bone cancer	1.06e-05	7.74e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MDM2—bone cancer	1.06e-05	7.73e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MDM2—bone cancer	1.06e-05	7.71e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—BRAF—bone cancer	1.05e-05	7.66e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PTGS2—bone cancer	1.04e-05	7.6e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MMP9—bone cancer	1.04e-05	7.57e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MMP9—bone cancer	1.03e-05	7.53e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—EGFR—bone cancer	1.02e-05	7.42e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—BRAF—bone cancer	1.02e-05	7.41e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—BRAF—bone cancer	1.02e-05	7.41e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PTGS2—bone cancer	1.01e-05	7.4e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—EGFR—bone cancer	9.84e-06	7.18e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—EGFR—bone cancer	9.84e-06	7.18e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PTGS2—bone cancer	9.81e-06	7.16e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PTGS2—bone cancer	9.81e-06	7.16e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—EGFR—bone cancer	9.75e-06	7.11e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MDM2—bone cancer	9.64e-06	7.03e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TP53—bone cancer	9.51e-06	6.94e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TP53—bone cancer	9.5e-06	6.93e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—JUN—bone cancer	9.36e-06	6.83e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—EGFR—bone cancer	9.3e-06	6.78e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—JUN—bone cancer	9.21e-06	6.72e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—JUN—bone cancer	9.19e-06	6.7e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GSTP1—bone cancer	9.14e-06	6.67e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MMP9—bone cancer	9.11e-06	6.64e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—EGFR—bone cancer	8.99e-06	6.56e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—EGFR—bone cancer	8.99e-06	6.56e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MMP9—bone cancer	8.96e-06	6.54e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MMP9—bone cancer	8.94e-06	6.52e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTGS2—bone cancer	8.82e-06	6.44e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MDM2—bone cancer	8.8e-06	6.42e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—EGFR—bone cancer	8.58e-06	6.26e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MDM2—bone cancer	8.51e-06	6.21e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MDM2—bone cancer	8.51e-06	6.21e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—EGFR—bone cancer	8.38e-06	6.12e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—JUN—bone cancer	8.38e-06	6.11e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—EGFR—bone cancer	8.34e-06	6.08e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—EGFR—bone cancer	8.3e-06	6.06e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—EGFR—bone cancer	8.3e-06	6.06e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—bone cancer	8.18e-06	5.97e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MMP9—bone cancer	8.15e-06	5.95e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTGS2—bone cancer	7.87e-06	5.74e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—JUN—bone cancer	7.64e-06	5.58e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MMP9—bone cancer	7.44e-06	5.43e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—JUN—bone cancer	7.4e-06	5.4e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—JUN—bone cancer	7.4e-06	5.4e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EGFR—bone cancer	7.36e-06	5.37e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTGS2—bone cancer	7.24e-06	5.28e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EGFR—bone cancer	7.24e-06	5.28e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EGFR—bone cancer	7.23e-06	5.27e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MMP9—bone cancer	7.2e-06	5.25e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MMP9—bone cancer	7.2e-06	5.25e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTGS2—bone cancer	7.18e-06	5.24e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—bone cancer	7.04e-06	5.13e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—bone cancer	7e-06	5.11e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EGFR—bone cancer	6.59e-06	4.81e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—bone cancer	6.18e-06	4.51e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTGS2—bone cancer	6.13e-06	4.48e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—bone cancer	6.08e-06	4.44e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—bone cancer	6.07e-06	4.43e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EGFR—bone cancer	6.01e-06	4.39e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EGFR—bone cancer	5.81e-06	4.24e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EGFR—bone cancer	5.81e-06	4.24e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—bone cancer	5.53e-06	4.04e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—bone cancer	5.05e-06	3.68e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—bone cancer	4.88e-06	3.56e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—bone cancer	4.88e-06	3.56e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTGS2—bone cancer	4.73e-06	3.45e-05	CbGpPWpGaD
